These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28799787)

  • 1. Increased Risk of Diabetes Among 6-24-Year-Olds Using Second Generation Antipsychotics.
    Xing S; Lee TA
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):782-791. PubMed ID: 28799787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.
    Xing S; Kim S; Schumock GT; Touchette DR; Calip GS; Leow AD; Lee TA
    Prim Care Companion CNS Disord; 2018 May; 20(3):. PubMed ID: 29873957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk for incident diabetes mellitus following initiation of second-generation antipsychotics among Medicaid-enrolled youths.
    Rubin DM; Kreider AR; Matone M; Huang YS; Feudtner C; Ross ME; Localio AR
    JAMA Pediatr; 2015 Apr; 169(4):e150285. PubMed ID: 25844991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
    Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
    J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine.
    Gooden KM; Bibeau KB; Wood J; Irizarry MC; Pan X; Allen J; Sampson T; Heim JM
    Curr Drug Saf; 2015; 10(2):152-8. PubMed ID: 24861991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents.
    Sohn M; Talbert J; Blumenschein K; Moga DC
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):583-91. PubMed ID: 25808613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
    Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic medication use among children and risk of diabetes mellitus.
    Andrade SE; Lo JC; Roblin D; Fouayzi H; Connor DF; Penfold RB; Chandra M; Reed G; Gurwitz JH
    Pediatrics; 2011 Dec; 128(6):1135-41. PubMed ID: 22106077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the risk of type 2 diabetes mellitus among children and adolescents with psychiatric disorders treated with atypical antipsychotics: a population-based nested case-control study.
    Lee H; Song DH; Kwon JW; Han E; Chang MJ; Kang HY
    Eur Child Adolesc Psychiatry; 2018 Oct; 27(10):1321-1334. PubMed ID: 29460164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.
    Bobo WV; Cooper WO; Stein CM; Olfson M; Graham D; Daugherty J; Fuchs DC; Ray WA
    JAMA Psychiatry; 2013 Oct; 70(10):1067-75. PubMed ID: 23965896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
    Gibson TB; Jing Y; Kim E; Bagalman E; Wang S; Whitehead R; Tran QV; Doshi JA
    Manag Care; 2010 Aug; 19(8):40-7. PubMed ID: 20822071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):642-651. PubMed ID: 28735693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic Medication Use in Children and Adolescents With Type 1 Diabetes.
    Liu S; Lagerberg T; Ludvigsson JF; Taylor MJ; Chang Z; D'Onofrio BM; Larsson H; Lichtenstein P; Gudbjörnsdottir S; Kuja-Halkola R; Butwicka A
    JAMA Netw Open; 2023 Oct; 6(10):e2336621. PubMed ID: 37787995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.
    Mehta S; Johnson ML; Chen H; Aparasu RR
    J Clin Psychiatry; 2010 Jun; 71(6):689-98. PubMed ID: 20573328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY.
    Lin CY; Wu YH; Wang HS; Chen PK; Lin YF; Chien IC
    Depress Anxiety; 2016 May; 33(5):435-43. PubMed ID: 26990119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke Risk Among Non-Elderly Users of Haloperidol or First-Generation Antipsychotics vs Second-Generation Antipsychotics: A Cohort Study from a US Health Insurance Claims Database.
    Fife D; Blacketer C; Knight K; Weaver J
    Drugs Real World Outcomes; 2021 Dec; 8(4):481-496. PubMed ID: 34109564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP study.
    Mamakou V; Hackinger S; Zengini E; Tsompanaki E; Marouli E; Serafetinidis I; Prins B; Karabela A; Glezou E; Southam L; Rayner NW; Kuchenbaecker K; Lamnissou K; Kontaxakis V; Dedoussis G; Gonidakis F; Thanopoulou A; Tentolouris N; Zeggini E
    BMC Psychiatry; 2018 Aug; 18(1):249. PubMed ID: 30071838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drugs and risk of burn injury in individuals with mental illness: a 10-year population-based case-control study.
    Chang CM; Wu KY; Chiu YW; Wu HT; Tsai YT; Chau YL; Tsai HJ
    Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):918-27. PubMed ID: 27476980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.
    Morrato EH; Newcomer JW; Kamat S; Baser O; Harnett J; Cuffel B
    Diabetes Care; 2009 Jun; 32(6):1037-42. PubMed ID: 19244091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression.
    Bhowmik D; Aparasu RR; Rajan SS; Sherer JT; Ochoa-Perez M; Chen H
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):551-61. PubMed ID: 25470655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.